September 2005
New studies on bone marrow failure diseases presented at scientific symposium Oct. 18-19
First international meeting on bone marrow diseases
The latest advances in aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other bone marrow failure diseases will be presented at the Bone Marrow Failure Scientific Symposium Oct. 18-19 in Washington, DC. This is the first international meeting covering all bone marrow diseases--life-threatening conditions for which, in most cases, the cause is unknown.
New research on stem cell transplantation, immunosuppressive treatments, drug therapies and alternative approaches will be presented by the world's leading physicians on bone marrow failure diseases.
The symposium is sponsored by the National Institutes of Health, including the Office of Rare Diseases, the National Heart, Lung and Blood Institute and the National Cancer Institute; and organized by Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF). Co-chairs are Jaroslaw Maciejewski, MD, PhD, Cleveland Clinic Foundation, Taussig Cancer Center and Neal S. Young, MD, National Heart, Lung and Blood Institute.
More information on the symposium is at AA&MDSIF's web site: http://www.aamds.org
What:
Bone Marrow Failure Scientific Symposium
Who:
--National Heart, Lung and Blood Institute
--National Cancer Institute
--Office of Rare Diseases
--Aplastic Anemia & MDS International Foundation, Inc.
When:
Oct. 18-19, 2005
Where:
L'Enfant Plaza Hotel, 480 L'Enfant Plaza, Washington, DC
Press must register for the symposium. Accredited journalists receive complimentary registration.
To register contact: Brian Ruberry, 301-948-1709, [email protected].
Founded in 1983, the Aplastic Anemia & MDS International Foundation, Inc. is dedicated to serving as a resourcefor patient assistance, advocacy, and support. AA&MDSIF provides patients and their families with educational materials and medical information, and supporting research to find treatments and cures for aplasticanemia (AA), myelodysplastic syndromes (MDS), paroxysmal nocturnal hemogloburina (PNH) and other bone marrow failure diseases.